{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:44:16Z","timestamp":1794663856507,"version":"4.9.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Diseases","doi-asserted-by":"publisher","award":["U54-NS108874"],"award-info":[{"award-number":["U54-NS108874"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014370","name":"Simons Foundation Autism Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>SCN2A-related disorders secondary to altered function in the voltage-gated sodium channel Nav1.2 are rare, with clinically heterogeneous expressions that include epilepsy, autism and multiple severe to profound impairments and other conditions. To advance understanding of the clinical phenotypes and their relationship to channel function, 81 patients (36 female, 44%, median age 5.4 years) with 69 unique SCN2A variants were systematically phenotyped and their Nav1.2 channel function systematically assessed. Participants were recruited through the FamileSCN2A Foundation.<\/jats:p>\n               <jats:p>Primary phenotype (epilepsy of neonatal onset, n = 27; infant onset, n = 18; and later onset n = 24; and autism without seizures, n = 12) was strongly correlated with a non-seizure severity index (P = 0.002), which was based on presence of severe impairments in gross motor, fine motor, communication abilities, gastrostomy tube dependence and diagnosis of cortical visual impairment and scoliosis. Non-seizure severity was greatest in the neonatal-onset group and least in the autism group (P = 0.002). Children with the lowest severity indices were still severely impaired, as reflected by an average Vineland Adaptive Behavior composite score of 49.5 (&amp;gt;3 standard deviations below the norm-referenced mean of the test). Epileptic spasms were significantly more common in infant-onset (67%) than in neonatal (22%) or later-onset (29%) epilepsy (P = 0.007). Primary phenotype was also strongly correlated with variant function (P &amp;lt; 0.0001); gain-of-function and mixed function variants predominated in neonatal-onset epilepsy, shifting to moderate loss of function in infant-onset epilepsy and to severe and complete loss of function in later-onset epilepsy and autism groups. Exploratory cluster analysis identified five groups, representing: (i) primarily later-onset epilepsy with moderate loss-of-function variants and low severity indices; (ii) mostly infant-onset epilepsy with moderate loss-of-function variants but higher severity indices; and (iii) late-onset and autism only, with the lowest severity indices (mostly zero) and severe\/complete loss-of-function variants. Two exclusively neonatal clusters were distinguished from each other largely on non-seizure severity scores and secondarily on variant function.<\/jats:p>\n               <jats:p>The relationship between primary phenotype and variant function emphasizes the role of developmental factors in the differential clinical expression of SCN2A variants based on their effects on Nav1.2 channel function. The non-seizure severity of SCN2A disorders depends on a combination of the age at seizure onset (primary phenotype) and variant function. As precision therapies for SCN2A-related disorders advance towards clinical trials, knowledge of the relationship between variant function and clinical disease expression will be valuable for identifying appropriate patients for these trials and in selecting efficient clinical outcomes.<\/jats:p>","DOI":"10.1093\/brain\/awae125","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:50:12Z","timestamp":1713876612000},"page":"2761-2774","source":"Crossref","is-referenced-by-count":58,"title":["Expanded clinical phenotype spectrum correlates with variant function in <i>SCN2A<\/i>-related disorders"],"prefix":"10.1093","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-5523","authenticated-orcid":false,"given":"Anne T","family":"Berg","sequence":"first","affiliation":[{"name":"Department of Neurology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"},{"name":"FamilieSCN2A Foundation , Longmeadow, MA 10116 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3713-630X","authenticated-orcid":false,"given":"Christopher H","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah Schust","family":"Myers","sequence":"additional","affiliation":[{"name":"FamilieSCN2A Foundation , Longmeadow, MA 10116 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Anderson","sequence":"additional","affiliation":[{"name":"Institute for Innovations in Developmental Sciences, Northwestern University , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Psychology, Illinois Institute of Technology , Chicago, IL 60616 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela J E","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Illinois Chicago , Chicago, IL 60616 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Paltell","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Illinois Chicago , Chicago, IL 60616 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda N","family":"Nili","sequence":"additional","affiliation":[{"name":"Department of Medical and Social Sciences, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc L","family":"DeKeyser","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V","family":"Abramova","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Nesbitt","sequence":"additional","affiliation":[{"name":"CLIRINX , Dublin A42YK18 , Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn M","family":"Egan","sequence":"additional","affiliation":[{"name":"FamilieSCN2A Foundation , Longmeadow, MA 10116 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos G","family":"Vanoye","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-966X","authenticated-orcid":false,"suffix":"Jr","given":"Alfred L","family":"George","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Northwestern University Feinberg School of Medicine , Chicago, IL 60611 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"2024091400015753200_awae125-B1","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1073\/pnas.111065098","article-title":"A missense mutation of the Na+ channel \u03b1II subunit gene Nav1.2 in a patient with febrile and afebrile seizures causes channel dysfunction","volume":"98","author":"Sugawara","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024091400015753200_awae125-B2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(02)09968-3","article-title":"Sodium-channel defects in benign familial neonatal-infantile seizures","volume":"360","author":"Heron","year":"2002","journal-title":"Lancet"},{"key":"2024091400015753200_awae125-B3","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1528-1167.2007.01049.x","article-title":"SCN2A mutations and benign familial neonatal-infantile seizures: The phenotypic spectrum","volume":"48","author":"Herlenius","year":"2007","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.0000000000001926","article-title":"SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures","volume":"85","author":"Howell","year":"2015","journal-title":"Neurology"},{"key":"2024091400015753200_awae125-B5","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/brain\/awx054","article-title":"Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders","volume":"140","author":"Wolff","year":"2017","journal-title":"Brain"},{"key":"2024091400015753200_awae125-B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpn.2019.12.016","article-title":"The phenotypic spectrum of SCN2A-related epilepsy","volume":"24","author":"Reynolds","year":"2020","journal-title":"Eur J Paediatr Neurol"},{"key":"2024091400015753200_awae125-B7","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ajmg.a.62595","article-title":"Further delineation of phenotypic spectrum of SCN2A-related disorder","volume":"188","author":"Richardson","year":"2022","journal-title":"Am J Med Genet"},{"key":"2024091400015753200_awae125-B8","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/humu.23619","article-title":"Relationship of electrophysiological dysfunction and clinical severity in SCN2A-related epilepsies","volume":"39","author":"Lauxmann","year":"2018","journal-title":"Hum Mutat"},{"key":"2024091400015753200_awae125-B9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2013.03.002","article-title":"SCN2A mutation is associated with infantile spasms and bitemporal glucose hypometabolism","volume":"49","author":"Sundaram","year":"2013","journal-title":"Pediatric Neurol"},{"key":"2024091400015753200_awae125-B10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ejpn.2016.05.020","article-title":"Episodic ataxia associated with a de novo SCN2A mutation","volume":"20","author":"Leach","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"2024091400015753200_awae125-B11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/YPG.0000000000000219","article-title":"Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum","volume":"29","author":"Suddaby","year":"2019","journal-title":"Psychiatr Genet"},{"key":"2024091400015753200_awae125-B12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tins.2018.03.011","article-title":"Progress in understanding and treating SCN2A-mediated disorders","volume":"41","author":"Sanders","year":"2018","journal-title":"Trends Neurosci"},{"key":"2024091400015753200_awae125-B13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/epi.16750","article-title":"SCN2A-Developmental and epileptic encephalopathies: Challenges to trial-readiness for non-seizure outcomes","volume":"62","author":"Berg","year":"2021","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s10020-019-0073-6","article-title":"Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes","volume":"25","author":"Begemann","year":"2019","journal-title":"Mol Med"},{"issue":"suppl 3","key":"2024091400015753200_awae125-B15","first-page":"S59","article-title":"Phenotypic spectrum and genetics of SCN2A-related disorders, treatment options, and outcomes in epilepsy and beyond","volume":"60","author":"Wolff","year":"2019","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biopsych.2017.01.009","article-title":"Opposing effects on NaV1.2 function underlie differences between SCN2A variants observed in individuals with autism spectrum disorder or infantile seizures","volume":"82","author":"Ben-Shalom","year":"2017","journal-title":"Biol Psychiatry"},{"key":"2024091400015753200_awae125-B17","doi-asserted-by":"crossref","first-page":"E5516","DOI":"10.1073\/pnas.1800077115","article-title":"Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of SCN2A epilepsy","volume":"115","author":"Berecki","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024091400015753200_awae125-B18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s42003-022-03454-1","article-title":"Functional correlates of clinical phenotype and severity in recurrent SCN2A variants","volume":"5","author":"Berecki","year":"2022","journal-title":"Commun Biol"},{"key":"2024091400015753200_awae125-B19","first-page":"100973","article-title":"CRID\u2014A unique, universal, patient-generated identifier to facilitate collaborative rare disease clinical research","volume":"31","author":"Nesbitt","year":"2022","journal-title":"IMU"},{"key":"2024091400015753200_awae125-B20","author":"Nesbitt"},{"key":"2024091400015753200_awae125-B21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0000000000004284","article-title":"Profile of neonatal epilepsies: Characteristics of a prospective US cohort","volume":"89","author":"Shellhaas","year":"2017","journal-title":"Neurology"},{"key":"2024091400015753200_awae125-B22","doi-asserted-by":"crossref","first-page":"107287","DOI":"10.1016\/j.yebeh.2020.107287","article-title":"Nonseizure consequences of Dravet syndrome, KCNQ2-DEE, KCNB1-DEE, Lennox\u2013Gastaut syndrome, ESES: A functional framework","volume":"111","author":"Berg","year":"2020","journal-title":"Epilepsy Behav"},{"key":"2024091400015753200_awae125-B23","doi-asserted-by":"crossref","first-page":"108953","DOI":"10.1016\/j.yebeh.2022.108953","article-title":"Measuring the inch stones for progress: Gross motor function in the developmental and epileptic encephalopathies","volume":"137","author":"Berg","year":"2022","journal-title":"Epilepsy Behav"},{"key":"2024091400015753200_awae125-B24","doi-asserted-by":"crossref","first-page":"108586","DOI":"10.1016\/j.yebeh.2022.108586","article-title":"Rare diseases\u2013rare outcomes: Assessing communication abilities for the developmental and epileptic encephalopathies","volume":"128","author":"Berg","year":"2022","journal-title":"Epilepsy Behav"},{"key":"2024091400015753200_awae125-B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/children4040030","article-title":"Overview of four functional classification systems commonly used in cerebral palsy","volume":"4","author":"Paulson","year":"2017","journal-title":"Children"},{"key":"2024091400015753200_awae125-B26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01942630903454930","article-title":"Reliability of the functional mobility scale for children with cerebral palsy","volume":"30","author":"Harvey","year":"2010","journal-title":"Phys Occup Ther Pediatr"},{"key":"2024091400015753200_awae125-B27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1469-8749.2000.tb00093.x","article-title":"The gross motor function classification system for cerebral palsy: A study of reliability and stability over time","volume":"42","author":"Wood","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"2024091400015753200_awae125-B28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1469-8749.2011.03996.x","article-title":"Developing and validating the communication function classification system for individuals with cerebral palsy","volume":"53","author":"Hidecker","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"2024091400015753200_awae125-B29","volume-title":"Vineland-3, vineland adaptive behavior scales","author":"Sparrow","year":"2016","edition":"3rd edn"},{"key":"2024091400015753200_awae125-B30","doi-asserted-by":"crossref","first-page":"e202313375","DOI":"10.1085\/jgp.202313375","article-title":"Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties","volume":"155","author":"Thompson","year":"2023","journal-title":"J Gen Physiol"},{"key":"2024091400015753200_awae125-B31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamapediatrics.2017.1743","article-title":"Early-Life epilepsies and the emerging role of genetic testing","volume":"171","author":"Berg","year":"2017","journal-title":"JAMA Pediatr"},{"key":"2024091400015753200_awae125-B32","author":"Federal Drug Adminstration"},{"key":"2024091400015753200_awae125-B33","author":"Federal Drug Adminstration"},{"key":"2024091400015753200_awae125-B34","author":"Federal Drug Adminstration"},{"key":"2024091400015753200_awae125-B35","first-page":"268","article-title":"Mental retardation in pediatric candidates for epilepsy surgery: The role of early seizure onset","volume":"42","author":"Vasconcellos","year":"2001","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B36","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.0013-9580.2005.03504.x","article-title":"Cognitive function in preschool children after epilepsy surgery: Rationale for early intervention","volume":"46","author":"Freitag","year":"2005","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1528-1167.2006.00904.x","article-title":"The development of intellectual abilities in pediatric temporal lobe epilepsy","volume":"48","author":"Cormack","year":"2007","journal-title":"Epilepsia"},{"key":"2024091400015753200_awae125-B38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/WNL.0b013e31826c1b55","article-title":"Age at onset of epilepsy, pharmacoresistance, and cognitive outcomes: A prospective cohort study","volume":"79","author":"Berg","year":"2012","journal-title":"Neurology"},{"key":"2024091400015753200_awae125-B39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2019.05.011","article-title":"Immediate outcomes in early life epilepsy: A contemporary account","volume":"97","author":"Berg","year":"2019","journal-title":"Epilepsy Behav"},{"key":"2024091400015753200_awae125-B40","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.0b013e3181f8812e","article-title":"SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain","volume":"75","author":"Liao","year":"2010","journal-title":"Neurology"},{"key":"2024091400015753200_awae125-B41","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/hmg\/ddac087","article-title":"Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice","volume":"31","author":"Echevarria-Cooper","year":"2022","journal-title":"Hum Mol Genet"},{"key":"2024091400015753200_awae125-B42","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1002\/mgg3.1250","article-title":"Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy","volume":"8","author":"Miao","year":"2020","journal-title":"Mol Genet Genomic Med"},{"key":"2024091400015753200_awae125-B43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.tins.2023.07.001","article-title":"Nonsense-mediated mRNA decay in neuronal physiology and neurodegeneration","volume":"46","author":"Petri\u0107 Howe","year":"2023","journal-title":"Trends Neurosci"},{"key":"2024091400015753200_awae125-B44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41580-019-0126-2","article-title":"Quality and quantity control of gene expression by nonsense-mediated mRNA decay","volume":"20","author":"Kurosaki","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2024091400015753200_awae125-B45","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13073-021-00949-0","article-title":"Developmental dynamics of voltage-gated sodium channel isoform expression in the human and mouse brain","volume":"13","author":"Liang","year":"2021","journal-title":"Genome Med"},{"key":"2024091400015753200_awae125-B46","doi-asserted-by":"crossref","first-page":"e201912442","DOI":"10.1085\/jgp.201912442","article-title":"Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants","volume":"152","author":"Thompson","year":"2020","journal-title":"J Gen Physiol"},{"key":"2024091400015753200_awae125-B47","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1093\/brain\/awz195","article-title":"Incidence and phenotypes of childhood-onset genetic epilepsies: A prospective population-based national cohort","volume":"142","author":"Symonds","year":"2019","journal-title":"Brain"},{"key":"2024091400015753200_awae125-B48","doi-asserted-by":"crossref","first-page":"109153","DOI":"10.1016\/j.yebeh.2023.109153","article-title":"Clinical characteristics of 80 subjects with KCNQ2-related encephalopathy: Results from a family-driven survey","volume":"142","author":"Cossu","year":"2023","journal-title":"Epilepsy Behav"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae125\/58606700\/awae125.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/8\/2761\/59116008\/awae125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/8\/2761\/59116008\/awae125.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T08:31:35Z","timestamp":1726302695000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/8\/2761\/7656659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,4,23]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae125","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,4,23]]}}}